Bridgewater, New Jersey — According to state and local development sources, Cellares plans to build out 118,000 square feet of new space in Bridgewater. The company plans to occupy the new space at 95 Corporate Drive in Bridgewater, on or about October 1, 2024. According to the company website Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century. The company is both developing and operating integrated technologies for cell therapy manufacturing to accelerate access to life-saving cell therapies. The companys Cell Shuttle integrates all the technologies required for the entire manufacturing process in a flexible and high-throughput platform that delivers true walk-away, end-to-end automation. Cell Shuttles will be deployed in Cellares Smart Factories around the world to meet total patient demand for cell therapies at global scale. Partnering with Cellares enables academics, biotechs, and pharma companies to accelerate drug development and scale out manufacturing, lower process failure rates, lower manufacturing costs, and meet global patient demand. The company is headquartered in South San Francisco, California with its commercial-scale IDMO Smart Factory in Bridgewater, New Jersey. The company is backed by world-class investors and has raised over $355 million in financing.

To learn more about Cellares, visit http://www.cellares.com/

Company Contact:
Fabian Gerlinghaus, Chief Executive Officer
fabian.gerlinghaus@cellares.com
https://www.linkedin.com/in/fabian-gerlinghaus/
833-235-5273

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.